glioblastoma
Showing NaN - NaN of 33
Glioblastoma, Venous Thromboembolism, Seizures Trial in Cleveland (Apple Watch)
Not yet recruiting
- Glioblastoma
- +2 more
- Apple Watch
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Nov 13, 2023
Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine
Recruiting
- Glioblastoma, IDH-wildtype
- +4 more
- Eflornithine (Dose Level 1)
- +3 more
-
Cleveland, OhioThe Cleveland Clinic
May 19, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))
Active, not recruiting
- Glioblastoma
- Ibrutinib
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023
Glioblastoma Trial in Cleveland (NICO Myriad and Tissue Preservation System (TPS))
Active, not recruiting
- Glioblastoma
- NICO Myriad and Tissue Preservation System (TPS)
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 13, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)
Active, not recruiting
- Glioblastoma
- LY2157299 monohydrate
- +2 more
-
Birmingham, Alabama
- +26 more
Oct 18, 2022
High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)
Not yet recruiting
- High Grade Glioma
- Glioblastoma
- Standard Surgical Treatment
- Intraoperative Electrocorticography
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Sep 30, 2022
Glioblastoma, Adult-type Diffuse Gliomas Trial in Worldwide (Pemigatinib)
Recruiting
- Glioblastoma
- Adult-type Diffuse Gliomas
-
Beverly Hills, California
- +83 more
Jul 25, 2022
Glioblastoma Multiforme, Glioblastoma Trial in United States (biological, procedure, drug)
Not yet recruiting
- Glioblastoma Multiforme
- Glioblastoma
- IGV-001 Cell Immunotherapy
- +3 more
-
Newark, Delaware
- +22 more
Jun 24, 2022
Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)
Active, not recruiting
- Glioblastoma Multiforme
- +6 more
- Dendritic cell immunotherapy
-
Birmingham, Alabama
- +85 more
May 12, 2022
Glioblastoma Trial in Worldwide (DSP-7888 Dosing Emulsion, Bevacizumab)
Active, not recruiting
- Glioblastoma
- DSP-7888 Dosing Emulsion
- Bevacizumab
-
Birmingham, Alabama
- +60 more
Apr 4, 2022
Glioblastoma Trial in Cleveland (Capecitabine, Bevacizumab)
Active, not recruiting
- Glioblastoma
-
Cleveland, OhioCleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Feb 22, 2022
Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)
Active, not recruiting
- Glioblastoma
- +3 more
- lerapolturev
- pembrolizumab
-
San Francisco, California
- +9 more
Nov 30, 2021
Glioblastoma Trial in United States (NeuroBlate System, Radiation therapy and temozolomide)
Terminated
- Glioblastoma
- NeuroBlate System
- Radiation therapy and temozolomide
-
Saint Louis, Missouri
- +3 more
Aug 23, 2021
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Glioblastoma Trial in Worldwide (Depatuxizumab mafodotin, Temozolomide, Lomustine)
Completed
- Glioblastoma
- Depatuxizumab mafodotin
- +2 more
-
Palo Alto, California
- +101 more
May 8, 2020
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,
Completed
- Glioblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Mobile, Alabama
- +329 more
Jul 22, 2019